Search Query :
5PZL
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase in complex with 2-({3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin-7-yl}oxy)acetamide Deposition Author(s): Sheriff, S.
Date: 2017-02-27 Method: X-RAY DIFFRACTION Resolution: 2.06 Å Organism(s): Hepatitis C Virus Genotype 1B (Isolate Con1) Sequences Data: 5PZL_A , 5PZL_B
5PZM
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase in complex with 3-[2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-5-yl]benzoic acid Deposition Author(s): Sheriff, S.
Date: 2017-02-27 Method: X-RAY DIFFRACTION Resolution: 2.54 Å Organism(s): Hepatitis C Virus Genotype 1B (Isolate Con1) Sequences Data: 5PZM_A , 5PZM_B
5PZN
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase in complex with 5-[3-(tert-butylcarbamoyl)phenyl]-2-(4-fluorophenyl)-n-methyl-1-benzofuran-3-carboxamide Deposition Author(s): Sheriff, S.
Date: 2017-02-27 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Hepatitis C Virus Genotype 1B (Isolate Con1) Sequences Data: 5PZN_A , 5PZN_B
5PZO
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase c316n in complex with 2-(4-fluorophenyl)-n-methyl-5-[3-({2-methyl-1-oxo-1-[(1,3,4-thiadiazol-2-yl)amino]propan-2-yl}carbamoyl)phenyl]-1-benzofuran-3-carboxamide Deposition Author(s): Sheriff, S.
Date: 2017-02-27 Method: X-RAY DIFFRACTION Resolution: 2.8 Å Organism(s): Hepatitis C Virus Genotype 1B (Isolate Con1) Sequences Data: 5PZO_A , 5PZO_B
5PZP
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase in complex with 4-fluoro-2-(4-fluorophenyl)-n-methyl-5-(2-methyl-5-{[1-(pyrimidin-2-yl)cyclopropyl]carbamoyl}phenyl)-1-benzofuran-3-carboxamide (bms-929075) Deposition Author(s): Sheriff, S.
Date: 2017-02-27 Method: X-RAY DIFFRACTION Resolution: 2.95 Å Organism(s): Hepatitis C Virus Genotype 1B (Isolate Con1) Sequences Data: 5PZP_A , 5PZP_B
5Q0D
Factor xia in complex with the inhibitor methyl [(7s)-7-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14-yl]carbamate Deposition Author(s): Sheriff, S.
Date: 2017-05-01 Method: X-RAY DIFFRACTION Resolution: 2.12 Å Organism(s): Homo Sapiens Sequences Data: 5Q0D_A
5Q0E
Factor xia in complex with the inhibitor methyl [(4s,8s)-8-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,5,6,7,8,10-octahydro-2h-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate Deposition Author(s): Sheriff, S.
Date: 2017-05-01 Method: X-RAY DIFFRACTION Resolution: 2.12 Å Organism(s): Homo Sapiens Sequences Data: 5Q0E_A
5Q0F
Factor xia in complex with the inhibitor methyl [(4r,5e,8s)-8-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2h-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate Deposition Author(s): Sheriff, S.
Date: 2017-05-01 Method: X-RAY DIFFRACTION Resolution: 2.12 Å Organism(s): Homo Sapiens Sequences Data: 5Q0F_A , 5Q0F_H
5Q0G
Factor xia in complex with the inhibitor methyl [(3r,7s)-7-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-ethyl-2-oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14-yl]carbamate Deposition Author(s): Sheriff, S.
Date: 2017-05-01 Method: X-RAY DIFFRACTION Resolution: 2.6 Å Organism(s): Homo Sapiens Sequences Data: 5Q0G_A
5Q0H
Factor xia in complex with the inhibitor methyl [(4r,5e,8s)-11-chloro-8-[(2,6-difluoro-4-methylbenzene-1-carbonyl)amino]-4-methyl-2-oxo-1,3,4,7,8,10-hexahydro-2h-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate Deposition Author(s): Sheriff, S.
Date: 2017-05-01 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 5Q0H_A